UnityPoint Health | Public Comments

2020 Public Comments

When relevant legislation, regulations, guidance, and other opportunities to shape policy related to health services research arise, UnityPoint Health may decide it is appropriate to develop an official position. The UnityPoint Health Government & External Affairs department serves as the primary liaison for regulatory submissions in response to state and federal rule-making and public requests for information, as well as communications advocating changes in state and federal policy direction or strategic initiatives.



Federal Comments

340B Drug Program Reporting

Agency: Centers for Medicare & Medicaid Services (CMS)

Proposed Information Collection on Hospital Survey for Specified Covered Outpatient Drugs (SCODs)

Additional Information

Transparency in Coverage

Agency: Department of Health & Human Services; Department of the Treasury; Department of Labor

Proposed Rule on Transparency in Coverage for Health Plans

Additional Information

Scope of Practice

Agency: Centers for Medicare & Medicaid Services (CMS)

Request for Feedback on Elimination of Supervision and Licensure Requirements that Limit Top of Licensure Practice

Additional Information


State Comments

There are currently no state comment letters available for 2020.

Legislative Positions and Collaborative Sign-On Letters

Prompt Pay Discount

Lead Organization: Wisconsin Hospital Association

Audience: Wisconsin Legislature

Sign-on memo dated February 2020 to urge the Assembly to include AB 841 to the Assembly floor calendar. This legislation clarifies a health care provider's ability to offer prompt-pay discounts to patients for out-of-pocket costs owed to a provider. This issue is included the UnityPoint Health 2020 State Legislative Agenda.

Drug Efficacy Study Implementation (DESI) drugs

Lead Organization: Civica Rx

Audience: Key Congressional Leaders, including Senator Chuck Grassley

Sign-on letter dated February 2020 to urge Congress to close loopholes that lead to unreasonable price increases for decades-old drugs as a result of periods of exclusivity grants by the Federal Drug Administration for former Drug Efficacy Study Implementation (DESI) drugs.

Iowa Immunizes

Lead Organization: Iowa Public Health Association

Audience: Iowa Legislature

Sign-on letter dated January 2020 to urge the Iowa Legislature to base their vaccine-related policy decisions on criteria that will:

  • Reduce barriers to giving safe and effective vaccines.
  • Encourage adherence to evidence-based vaccine recommendations.
  • Support providing accurate, science-based immunization information.

Executive Order Summaries

At the Federal level, Executive Orders (EOs) are issued by the President. The EOs listed below announce regulatory and administrative priorities and often foreshadow future administrative rule-making efforts. UnityPoint Health often summarizes EOs impacting healthcare to inform advocacy efforts.

There are currently no summaries of EOs available for 2020.

For Further Information:

Please email Cathy Simmons, Executive Director of Regulatory Affairs.